Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.6 - $25.06 $276,360 - $353,346
-14,100 Reduced 63.8%
8,000 $173,000
Q2 2024

Aug 14, 2024

BUY
$19.09 - $22.57 $290,168 - $343,064
15,200 Added 220.29%
22,100 $433,000
Q1 2024

May 15, 2024

BUY
$21.55 - $29.29 $105,595 - $143,521
4,900 Added 245.0%
6,900 $149,000
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $47,280 - $60,540
2,000 New
2,000 $57,000
Q1 2023

May 15, 2023

BUY
$29.39 - $36.27 $126,377 - $155,961
4,300 New
4,300 $134,000
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $3,792 - $6,374
100 New
100 $4,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.